Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619000798167
Ethics application status
Approved
Date submitted
22/05/2019
Date registered
30/05/2019
Date last updated
15/08/2022
Date data sharing statement initially provided
30/05/2019
Type of registration
Prospectively registered

Titles & IDs
Public title
Reducing peripheral intravenous cannula failure in neonates
Scientific title
Effect of a splint and intravenous protection device on peripheral intravenous cannula failure in neonates.
Secondary ID [1] 298307 0
Nil
Universal Trial Number (UTN)
Trial acronym
IV-Protect
Linked study record
Nil

Health condition
Health condition(s) or problem(s) studied:
IV cannula failure
 312936 0
IV extravasation 312937 0
Condition category
Condition code
Reproductive Health and Childbirth 311429 311429 0 0
Complications of newborn

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
A randomised controlled trial to assess whether using a specifically designed splint and protection device may be useful to prevent (peripheral intravenous cannula) PIVC failure as compared to standard splinting and securement in the neonatal population. Specific splint and IV protective product (I.V. house, Inc, MO, USA) – 939S-Ultra TLC Foam Padded Wrist Splint with Two Straps and Velcro Closure, or 949XS TLC Foam Padded Foot Splint with Two Straps and Velcro Closure; in conjunction with the I.V. House 330 Series I.V. House UltraDressing IV site protector.
Intervention will be administered by any health professional inserting and/or securing the PIVC. The intervention will continue for the life of that PIVC which may be minutes, hours or days till the PIVC is removed. This is a likely to be less than 7 days in most cases.
Adherence to intervention will be ensured by observation and cannula log maintained by bedside nurses.
Intervention code [1] 314538 0
Treatment: Devices
Comparator / control treatment
Splinting and dressing as per current standard care at Monash Newborn. This includes splinting with a Parker Healthcare (Mitcham, VIC, Australia) APM602 disposable IV arm board with flex insert, secured with Leukoplast (BSN medical GmbH, Hamburg, Germany) tape
Control group
Active

Outcomes
Primary outcome [1] 320150 0
Rates of PIVC failure due to any cause (as observed clinically and recorded on cannula log)
Timepoint [1] 320150 0
At end of need for PIVC for that episode (only one PIVC insertion per patient will be randomised). A non-failed PIVC will indicate a PIVC which is electively removed, when it is no longer required.
Secondary outcome [1] 370714 0
Rates of extravasation (Clinical observation)
Timepoint [1] 370714 0
At PIVC removal or end of PIVC use
Secondary outcome [2] 370767 0
Rates of phlebitis (Clinical observation)
Timepoint [2] 370767 0
At PIVC removal or end of PIVC use
Secondary outcome [3] 370768 0
Rates of dislodgement (Clinical observation)
Timepoint [3] 370768 0
At PIVC removal or end of PIVC use
Secondary outcome [4] 370769 0
Rates of any other event related to PIVC (Clinical observation)
Timepoint [4] 370769 0
At PIVC removal or end of PIVC use

Eligibility
Key inclusion criteria
All neonates admitted to the neonatal unit at Monash Children's Hospital, Clayton with a gestation at birth of more than 35 weeks and birth weight of more than 2500g who require a peripheral intravenous cannula.
Only one cannulation per neonate will be included in the study, and this will preferably be the first cannulation.
Minimum age
0 Hours
Maximum age
28 Days
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Neonates who are expected to require the PIVC for a period of less than 24 hours will be excluded from the study

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
31/05/2019
Actual
31/07/2019
Date of last participant enrolment
Anticipated
31/12/2022
Actual
Date of last data collection
Anticipated
31/12/2022
Actual
Sample size
Target
100
Accrual to date
67
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 13809 0
Monash Children’s Hospital - Clayton
Recruitment postcode(s) [1] 26562 0
3168 - Clayton

Funding & Sponsors
Funding source category [1] 302847 0
Hospital
Name [1] 302847 0
Monash Health
Country [1] 302847 0
Australia
Primary sponsor type
Hospital
Name
Monash Health
Address
246 Clayton Road
Clayton Vic 3168
Country
Australia
Secondary sponsor category [1] 302815 0
None
Name [1] 302815 0
None
Address [1] 302815 0
None
Country [1] 302815 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 303424 0
Monash HREC
Ethics committee address [1] 303424 0
Ethics committee country [1] 303424 0
Australia
Date submitted for ethics approval [1] 303424 0
Approval date [1] 303424 0
20/05/2019
Ethics approval number [1] 303424 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 93630 0
Dr Atul Malhotra
Address 93630 0
Monash Health
246 Clayton Rd
Clayton VIC 3168
Country 93630 0
Australia
Phone 93630 0
+61 3 85723650
Fax 93630 0
Email 93630 0
[email protected]
Contact person for public queries
Name 93631 0
Atul Malhotra
Address 93631 0
Monash Health
246 Clayton Rd
Clayton VIC 3168
Country 93631 0
Australia
Phone 93631 0
+61 3 85723650
Fax 93631 0
Email 93631 0
[email protected]
Contact person for scientific queries
Name 93632 0
Atul Malhotra
Address 93632 0
Monash Health
246 Clayton Rd
Clayton VIC 3168
Country 93632 0
Australia
Phone 93632 0
+61 3 85723650
Fax 93632 0
Email 93632 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.